Veru Healthcare

November 4, 2019

Veru Completes Enrollment for Zuclomiphene Citrate Trial for ADT-Induced Hot Flashes in PC

News

Veru Healthcare has completed patient enrollment for its Phase 2 clinical trial evaluating the use of zuclomiphene citrate (VERU-944) for the treatment of hot flashes in men receiving hormone therapy for ... Read more

May 26, 2017

VERU-944 Therapy for Hot Flashes in Men Receiving Prostate Cancer Hormone Treatment Heads to Trial

News

Veru Healthcare is set to begin a Phase 2 clinical trial evaluating VERU-944 (APP-944) for the treatment of hot flashes in men receiving hormone therapy for prostate cancer. The announcement comes ... Read more